Sarepta Therapeutics, INC. (SRPT) — SC 13G Filings
All SC 13G filings from Sarepta Therapeutics, INC.. Browse 1 Passive Stake Filing reports with AI-powered summaries and risk analysis.
SC 13G Filings (1)
-
Capital International Investors Takes 8.0% Stake in Sarepta
— Feb 9, 2024 Risk: low
Capital International Investors, a major investment firm, reported owning 7,377,295 shares of Sarepta Therapeutics, Inc. (SRPT) common stock as of December 29,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX